Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00277095 · ClinicalTrials.gov registry record · NA
ProACT Therapy for the Treatment of Stress Urinary Incontinence in Males
A NA study, sponsored by Uromedica.
- Completed
- Registry status
- NA
- Development phase
- 123
- Enrollment target
NCT00277095 is a NA study that has completed, run by Uromedica. The registered enrollment target is 123 participants.
The verdict
NCT00277095, a NA study, has completed, sponsored by Uromedica.
- COMPLETED
- Registry status
- NA
- Development phase
- 123 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the safety and effectiveness of a minimally invasive surgical procedure in up to 109 male patients. The ProACT device is designed to treat men who have stress urinary incontinence arising from intrinsic sphincter deficiency following an operation performed on the prostate for cancer or for benign prostatic hyperplasia. Two adjustable balloons (one on each side of the urethra) are implanted to treat urinary stress incontinence. The results will be analyzed to demonstrate the effects of the device as well as its associated risks. Therapeutic success will be based on whether patients demonstrate at least a 50% reduction in pad weight at 18 months follow-up compared to the pad weight results at baseline.
Interventions
- DEVICE ProACT (Adjustable Continence Therapy)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2005-08 |
| Est. Completion | 2017-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00277095
The ClinicalTrials.gov registry entry for NCT00277095 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Uromedica, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ProACT (Adjustable Continence Therapy) is the first listed.
NCT00277095 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00277095 about?
NCT00277095 is a clinical study titled "ProACT Therapy for the Treatment of Stress Urinary Incontinence in Males". The purpose of the study is to evaluate the safety and effectiveness of a minimally invasive surgical procedure in up to 109 male patients. The ProACT device is designed to treat men who have stress urinary incontinence arising from intrinsic sphincter deficiency following an operation performed on ...
What is the current status of trial NCT00277095?
This trial is currently completed. It is a NA study. The enrollment target is 123 participants. The study started on 2005-08. Estimated completion is 2017-12.
What interventions are being tested in trial NCT00277095?
The interventions under investigation include: ProACT (Adjustable Continence Therapy) (DEVICE).
Who is sponsoring clinical trial NCT00277095?
This trial is sponsored by Uromedica, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.